Aevi Genomic Medicine (GNMX) Misses Q1 EPS by 2c; to Initiate Phase 2 Trial of AEVI-001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Aevi Genomic Medicine (GNMX) Misses Q1 EPS by 2c; to Initiate Phase 2 Trial of AEVI-001
(NYSE: GNMX) Delayed: 31.94 -0.23 (0.71%)
Previous Close $32.17    52 Week High $ 
Open $31.92    52 Week Low $ 
Day High $31.94    P/E N/A 
Day Low $31.72    EPS $ 
Volume 1,444